PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35348194-0	2022	Salvianolic acid B acts against non-small cell lung cancer A549 cells via inactivation of the MAPK and Smad2/3 signaling pathways.	salvianolic acid B	0-18	SMAD family member 2	Homo sapiens	103-110	
35348194-9	2022	The results of the present study indicated that the underlying active mechanism of Sal B in NSCLC may be closely related to the impeded activation of the MAPK and Smad2/3 signaling pathways.	salvianolic acid B	83-88	SMAD family member 2	Homo sapiens	163-170	
33732314-3	2021	The aims of the present study were to investigate the underlying mechanisms of Sal B on acute and chronic liver injury induced by CCl4 and H2O2, and its effects on p-Smad2C/L.	salvianolic acid B	79-84	SMAD family member 2	Homo sapiens	166-171	
33899116-11	2021	Similarly, Sal B significantly decreased TGF-beta1-induced TbetaR-I, TbetaR-II, p-Smad2/3, MMP-2 and MMP-9 mRNA and protein expression levels in NPFs.	salvianolic acid B	11-16	SMAD family member 2	Homo sapiens	82-89